GENE ONLINE|News &
Immunic Announces 1-for-10 Reverse Stock Split Effective April 24, 2026
Immunic, Inc., a clinical-stage biopharmaceutical company, has announced the implementation of a 1-for-10 reverse stock split. The move will consolidate every ten shares of the company’s common stock into one share. This adjustment is set to take effect at the start of trading on April 24, 2026.
The reverse stock split aims to reduce the total number of outstanding shares and proportionally increase the per-share price. Immunic confirmed that no fractional shares will be issued as part of this process; instead, shareholders entitled to fractions will receive cash payments based on the post-split share value. The company stated that this decision was approved by its board of directors and aligns with its broader corporate strategy.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 23, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10
